PSG Executive Committee

The PSG is governed by a Constitution and Bylaws and an elected Executive Committee that is primarily responsible for the direction and oversight of its research projects and activities.

Key Documents

Click below to view/download PDF documents:

PSG Bylaws
PSG Policies & Procedures
Conflict of Interest Guidelines

Executive Committee Overview

The PSG Executive Committee oversees all the PSG study steering committees, the Scientific Review Committee, the Mentoring Committee, the Nominating Committee, the Credentials Committee, the Publications Committee, the Standards Committee, the Study Budget Committee, and the Symposia Committee (Click here to view/download the PSG Standing Committee Members list). The Executive Committee is also responsible for overseeing the PSG working groups (Atypical Parkinsonian Disorders, Cognitive/Psychiatric (Behavior), Biomarkers, Genetics and Environmental Risk, Health/Care Outcomes and Disparities, Other Non-Motor Features of PD, Functional Neurosurgical and Motor Features of PD) that are responsible for developing new PSG projects. PSG members interested in joining a working group may contact the Chair of that group.

Executive Committee Members

PSG Executive Committee Members:
Cindy Casaceli (2015-2018)
Kelvin Chou (2017-2020)
Eric Macklin (2015-2018)
Peter LeWitt (2015-2018)
Brad Racette (2018-2021)
Marie Saint-Hilaire (2018-2021)
David K. Simon (2017-2020)
Karen Williams (2018-2021)

Ex-officio members:
Karen Rabinowitz, JD, Legal Counsel
Roseanna Battista, BS, Administrative Manager
Donna Moszkowicz, CMP, Development and Event Manager
Cindy Wan, BS, PSG Financial Administrator (2013-present)

PSG Chair and Co-chair:

Michael Schwarzschild, MD, PhD, Chair (2018-2024)

Hubert Fernandez, MD, Co-Chair (2018-2024)

Click here to download the Executive Committee position statement.

Click here to download the Standing Committee list.